同仁堂国药(股票代码:03613)于2026年7月3日提交的公告显示,截至2026年6月30日,公司总股本未发生变化。
根据公告,公司的普通股已发行股份数量在6月末为837,100,000股,与上月末持平,库存股份数为0股,报告期内未发生新增发行、回购或注销,也未披露任何股份期权、可换股票据、权证或股权激励计划的变动。公司确认其公众持股量持续符合香港联交所《上市规则》的相关要求。
公告同时说明,所有应向公司收取的发行款项已完成或正在进行中,公司严格遵守了香港联交所《上市规则》及相关法律法规的要求。本次月报表由公司秘书曾凤仪签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.